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Abstract 
Background: The robust desmoplasia associated with head and neck squamous cell carcinoma (HNSCC) suggests 
that the tumor microenvironment may be an important component in the pathophysiology of this cancer. Moreover, 
the high recurrence rate and poor clinical response to chemotherapy and radiation treatment further underscores 
that the non-cancerous cells of the microenvironment, such as mesenchymal stromal cells (MSCs), cancer associated 
fibroblasts (CAFs), and pericytes, may be important in the pathophysiology of HNSCC.
Methods: Confocal microscopy and immunohistomchemistry approaches were used to identify MSCs tumor 
microenvironment from patients with oral cavity and oral pharyngeal squamous cell carcinoma (SCC). In vitro Boyden 
chamber assays and multiplex magnetic bead assays were used to measure MSC chemotaxis and to identify the 
chemokines secreted by JHU-011, -012, -019, three cells lines derived from patients with oral pharyngeal SCC.
Results: We show here that MSCs reside in the tumor microenvironment of patients with oral cavity and oral pharyn-
geal SCC and are recruited via paracrine mediated tumor cell secretion of (platelet derived growth factor) PDGF-AA. 
The MSC markers CD90+, CD105+, and gremlin-1+ were found to co-localize on cells within the tumor microenvi-
ronment in oral cavity SCC specimens distinct from α-smooth muscle actin staining CAFs. The conditioned media 
from JHU-011, -012, and -019 caused a significant increase in MSC migration (>60%) and invasion (>50%; p < 0.0001) 
compared to oral keratinocyte (OKT) controls. Tumor cell induced MSC chemotaxis appears to be mediated through 
paracrine secretion of PDGF-AA as inhibition of the PDGF-AA receptor, PDGFR-α but not PDGFR-β, resulted in near 
arrest of MSC chemotaxis (p < 0.0001).
Conclusions: Tumor microenvironment expression of PDGFR-α has been shown to correlate with a worse prognosis in 
patients with prostate, breast, ovarian, non-small cell lung cancer and osteosarcoma. This is the first evidence that a similar 
signaling paradigm may be present in HNSCC. PDGFR-α inhibitors have not been studied as adjunctive treatment options 
in the management of HNSCC and may prove to be an important driver of the malignant phenotype in this setting.
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Background
Head and neck squamous cell carcinoma (HNSCC) is the 
fifth most common cancer worldwide, the vast majority 
arising from the oral cavity (OC) and oropharynx (OP). 
Despite earlier detection rates, multimodality therapy 
and surgical advances, the overall 5  year survival rate 
for advanced HNSCC is poor (<25%), and has remained 
largely unchanged in the last 30 years. Local regional fail-
ure following attempts at curative treatment with either 
primary surgical excision and/or concurrent chemo-
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The clinicopathologic response of HNSCC to conven-
tional protocols including surgical excision and chemo-
radiotherapy suggests that treatment strategies directed 
toward tumor cells alone are inadequate and that target-
ing non-cancerous cells in the tumor microenvironment 
may improve clinical outcomes.
Mesenchymal stromal cells (MSCs), myofibroblasts/
cancer associated fibroblasts (CAFs), pericytes, and other 
non-cancerous cells form a dense desmoplastic micro-
environment around tumor cells and are known to be 
critical contributors to the growth of several solid tumors 
[1]. This rich desmoplastic reaction is a pathognomonic 
feature of HNSCC further driving the hypothesis that the 
tumor microenvironment is likely a key component in 
pathophysiology of this cancer. In addition to promoting 
cancer growth, MSCs and their differentiated progeny, 
CAFs, are known to confer resistance to chemotherapy 
and radiation, drive the development of cancer stem cells 
(CSC), and evade host immune responses [2]. The impor-
tance of the tumor microenvironment and its crosstalk 
with cancer cells are increasingly being recognized as 
important steps in the pathogenesis and progression of 
several cancers [1].
It is now believed that bone marrow derived MSCs 
serve a significant source of differentiated CAFs in the 
tumor microenvironment [2–4]. In models of gastric can-
cer, 20% of CAFs were shown to originate from the bone 
marrow and derived of MSCs [4]. In this model, bone 
marrow derived MSCs are thought to home to tumors 
via paracrine signals generated by the tumor itself [2, 5, 
6], and once resident within the local microenvironment 
MSCs serve as important precursors for CAFs, together 
enhancing tumor growth through autocrine and parac-
rine signaling pathways [2, 7]. Co-culture of bone mar-
row derived MSCs, either direct or indirect via transwell 
culture, with breast cancer cells has been shown to signif-
icantly increase aldehyde dehydrogenase (ALDH) expres-
sion, a CSC marker [2]. The conditioned media alone 
from MSC was not enough to induce increased ALDH 
expression on the breast cancer cells, suggesting that the 
paracrine signaling feedback loop between the breast 
cancer cells and MSCs is necessary to drive the increase 
in ALDH expression [2].
Despite this recent knowledge in other epithelial can-
cer models, the role of MSCs, their localization within 
the tumor microenvironment of any HNSCC subsite 
including the OC and OP, and the signals governing MSC 
chemotaxis in this setting have not yet been described. 
Liotta et  al. recently reported MSCs to be enriched in 
CD90+ stromal fraction of cells isolated from HNSCC 
tumors [8]. Prince et  al. have also described isolation 
of ALDH+/CD44+ cells from patients with HNSCC are 
able to generate tumors de novo, and designated these 
as CSCs for their ability to recapitulate a heterogeneous 
tumor [9]. We report here that MSCs reside within the 
tumor microenvironment from patients with OC and 
OPSCC along with α-SMA+ CAFs. Moreover, HNSCC-




Head and neck cancer cell lines JHU-011, JHU-012, 
JHU-019, JHU-022 (derived from human oropharyngeal 
tumors) and OKF-TERT1 human, immortalized oral 
keratinocyte cells (OKT) were generously provided by Dr. 
Vicente Resto, (Galveston, TX). Cells were maintained in 
RPMI 1640 medium containing glutamine supplemented 
with 10% fetal bovine serum at 37 °C in 5% CO2. Primary 
bone marrow-derived human mesenchymal stromal cells 
(MSCs) were obtained from Stem Cell Technologies 
(Vancouver, BC) and maintained according to the man-
ufacturers recommendations. The human HNSCC cell 
lines used in these studies have been extensively charac-
terized both in vitro and in vivo [10, 11].
MSC migration and invasion
MSC chemotaxis was determined using the modified 
Boyden chamber assay, as previously described [12]. 
Briefly, 2.5 × 105 MSCs in serum free media were seeded 
on the filter in the upper chamber of the transwell in a 
final volume of 250  µl. The lower chamber contained 
serum free control media, or conditioned media from 
JHU-011, -012, -019, -022 or OKT cells. The entire mem-
brane was then analyzed and cells counted in five sections 
at 40×. MSC migration was quantified as a percentage 
increase or decrease normalized to OKT cell induced 
MSC migration. The average number of cells per mem-
brane was determined that number, divided by the area 
of the microscope viewing field, and multiplied by the 
entire area of the transwell insert. All experiments were 
performed in triplicate for n ≥ 3. To determine chemoin-
vasion, transwells were prepared as described above and 
the filter plated with Matrigel™ (BD Biosciences, Franklin 
Lake, NJ) on the upper surface according to the manufac-
turer’s protocol.
Histology and immunohistochemistry
Standard immunohistochemistry techniques were used 
as previously described on archival tissue from patients 
with HNSCC (Legacy Tumor Bank, Portland, Oregon) 
and the University of Texas Medical Branch, through 
an approved IRB study. Briefly, tissue sections of tongue 
and tonsil squamous cell carcinomas were deparaffi-
nized and rehydrated, and antigen retrieval was per-
formed in citrate-based antigen unmasking solution 
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(Vector Laboratories, Burlingame, CA) at 90  °C for 
20  min. Endogenous peroxidase was blocked using 3% 
hydrogen peroxide for 10  min. Nonspecific protein 
blocking was followed by incubation with primary and 
secondary antibodies and with ABC reagent, Vecstatin 
Elite ABC kit (Vector) was used following manufacturers 
recommendations. Isotype controls were incubated with 
rabbit IgG (Vector). ImmPact DAB (Vector) was used as 
the chromogen and hematoxylin (Sigma) as the counter-
stain. All stained sections were evaluated using a Leica 
DM LB microscope. Microphotographs were taken with 
a mounted Pixera PVC 100C camera. The percentage of 
gremlin-1 positive cells was measured using ImageJ and 
performing a threshold cutoff analysis. Experiments were 
performed in triplicate.
Confocal microscopy
Confocal microscopy on frozen human oral cavity tis-
sue sections (10 μm thickness) was performed as previ-
ously described with minor modifications [13]. Briefly, 
frozen human oral cavity tissue sections were fixed in 
1% paraformaldehyde for 20  min at room temperature, 
blocked with normal murine serum (2.5% in PBS) for 
15  min at room temperature, and then incubated with 
mix of AF®488-conjugated anti-α-SMA monoclonal 
Abs (0.2  µg/ml), AF®555 conjugated anti-human grem-
lin mouse mAbs (1  µg/ml) and/or AF®647 anti-human 
CD90 mouse mAbs for 1  h at room temperature. Each 
staining step was followed by six washes with PBS with 
Ca++/Mg++. Isotype controls were included in the analy-
ses. The sections were then mounted in SlowFade® Gold 
antifade reagent with DAPI (Life Technology, Inc.). Con-
focal microscopy was performed with a Zeiss LSM510 
META laser-scanning confocal microscope (Carl Zeiss, 
Thornwood, NY) and confocal images analyzed using 
the LSM software and the following assignment of color: 
AF®-488 antibodies were depicted as green, AF®-555 
antibodies were depicted as red, and AF®-647 depicted as 
blue. In merged images, co-localization of green and red 
antibodies resulted in yellow/orange image and co-local-
ization of red and blue antibodies resulted in a magenta/
pink image.
Real‑time RT‑PCR
Real-time RT-PCR analysis was performed as previously 
described [14] according to the Applied Biosystems’s 
two-step RT real-time PCR protocol (Applied Biosys-
tems, Foster City, CA). All reagents were purchased from 
Life Science Technology Inc. The appropriate assays-on-
demand™ gene expression assay mix (Applied Biosys-
tems) for human actin RNA and the gene of interest (a 
20× mix of unlabeled PCR primers and TaqMan® MGB 
probe, FAM™ dye-labeled) and 2 µl of cDNA were added 
to the PCR reaction step. The reactions were carried out 
in a 20 µl final volume using a Bio-Rad Q5 real-time PCR 
machine according to the following protocol: 2  min at 
50 °C, 10 min at 95 °C (1 cycle) and 15 s at 95 °C and 1 
min at 60 °C (40 cycles).
Western‑immunoblotting
Standard Western blot analysis was performed on 10 μg 
of protein from the cell lines of interest using protocols 
as previously described [13]. PDGFRβ was purchased 
from Millipore (catalog # 06-495), PDGFRα (product # 
9360) and GP130 from Cell Signaling Technology (prod-
uct #3732), and α-IL6R from Thermo scientific (catalog 
#PA5-27975).
Cytokine expression and production
Cytokine production was measured in the supernatants 
of the conditioned media from MSCs, primary fibro-
blasts-7049, OKT, and OPSCC JHU-011, -012, and -019 
using appropriate cytokine ELISA kits (CXCL1, CXCL5, 
CXCL6, CXCL7); Milliplex kit (5-plex) IL6, IL8, VEGF, 
GRO, RANTES) (Millipore) and Bioplex human cytokine 
21-plex, and 27-plex (Array kit; Bio-Rad) according to 
the manufacturer’s instructions. The Bio-Plex Array 
Reader and 96-well plate microplate platform were used 
as a reading system using xMAP detection technology 
(Bio-Rad).
Statistical analysis
Unless otherwise indicated, the results were expressed 
as the mean ± SEM of data obtained from at least three 
independent experiments done with duplicate or tripli-
cate sets. For nonparametric analysis differences between 
means were evaluated by two-way ANOVA. For para-
metric analysis paired (two-tailed) t test was performed. 
Values of p < 0.05 were considered statistically significant 
(Graphpad Prism 7.0).
Results
Mesenchymal stromal cells are identified within the OC 
and OPSCC tumor microenvironment
Using an immunohistochemical approach, human 
OPSCC specimens (tonsil) were screened using the MSC 
marker gremlin-1. Gremlin-1, a more recently described 
MSC marker, is thought to specifically recognize periph-
erally migrating MSCs of bone marrow origin in models 
of gastric cancer [15]. Worthley et  al. identified grem-
lin-1+ stromal cells co-localized with the epithelial stem 
cell niche within the gastrointestinal tract and specifically 
labeled mesenchymal cells that gives rise to α-smooth 
muscle actin (αSMA+) myofibroblast/CAFs [15, 16]. 
Representative immunostaining images from OPSCC 
tumor samples demonstrates the presence of gremlin-1 
Page 4 of 10Watts et al. J Transl Med  (2016) 14:337 
positive cells (Fig. 1a–c) in the tumor microenvironment 
from patient OPSCC tumor samples and labeled cells 
distinct from the hematopoietic lineage markers CD14 
(Fig. 1g–i) and CD45 (Additional file 1: Figure S1A–C) an 
important distinction for determining cells of mesenchy-
mal lineage. α-SMA, a mesenchymal lineage marker was 
also used to characterize the OPSCC tumor microenvi-
ronment. α-SMA + cells were seen in the tumor stroma 
and thought to represent myofibroblasts, which are cells 
thought to be progeny of MSCs (Fig.  1d–f). Approxi-
mately 18% of cells within the tumor microenvironment 
were noted to be gremlin-1 positive compared to IgG 
negative controls (Additional file 2: Figure S2).
High resolution confocal microscopy demonstrates co-
localization of the MSC markers gremlin-1 and CD90 of 
OCSCC (Fig. 2). Representative photomicrographs from 
2/5 patient tumor samples and one adjacent normal 
control are shown. In Fig.  2, gremlin-1 immunostain-
ing (B, F, and J) is denoted in red and CD90 immu-
nostaining (C, G, and K) is denoted in blue. A magenta 
color signifies co-localization of gremlin-1 and CD90 
on merged images (D, H, and L). Z-stack image analy-
sis with orthogonal sectioning was performed on tumor 
specimen 1 (T1; Fig.  2D). At the cross-hairs (white 
arrow), cells are analyzed in both the x and y-planes, as 
denoted by the white asterisks, further supporting that 
the magenta color signal represents both co-localization 
of gremlin-1 and CD90 throughout the tissue slice. We 
also observed co-localization of gremlin-1 with the mes-
enchymal lineage marker CD105 (Additional file 3: Fig-
ure S4A) in the tumor stroma. Adjacent normal mucosa 
was observed to have relatively few MSCs compared to 
tumor specimens in 3/3 patient samples and a repre-
sentative immunostaining shown in Fig. 2I–L). Further, 
the co-localization of gremlin-1+/CD90+ double posi-
tive cells with α-SMA+, which identifies differentiated 
myofibroblasts (known as CAFs in tumors) was limited 
(Fig.  3). Additionally, no co-localization with hemat-
opoietic marker CD45+ cells were observed (Additional 
file  3: Figure S4B). Taken together these observations 
support our hypothesis that the gremlin-1+/CD90  +/
CD105 + cells in the OC and OPSCC tumor microenvi-
ronment are MSCs. 
MSCs migrated toward OPSCC tumor cell condition media
Having identified cells of bone marrow mesenchymal ori-
gin in the tumor microenvironment from patients with 
OC- and OPSCC, we next tested whether tumor cells 
secrete chemotactic factors capable of inducing MSC 
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Fig. 1 MSCs reside in the OPSCC (human tonsil) tumor stromal microenvironment. The black arrows denote the tumor microenvironment (TM). 
Representative immunohistological sections of human OPSCC demonstrates the presence of a distinct population of gremlin-1+ MSCs in the TM 
(a–c). The black square denotes areas viewed at higher magnification. Cells positive for the myofibroblast/CAF marker, α-SMA+ , were also present 
within the TM (d–f). A small population of CD14+ lymphocytes are seen at higher power magnification, representing cells of hematopoietic lineage 
(g–i). The above photomicrographs are serial sections (4 μm thickness)
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from 3 well characterized OPSCC cell lines (JHU-011, 
-012, and -019 [11]) were shown to cause a >60% increase 
in MSC migration (Fig. 4a) and a >50% increase in MSC 
invasion (Fig. 4b) compared to normal oral keratinocytes 
(OKT; p  <  0.0001) and serum free controls (Additional 
file 4: Figure S5). These observations suggested that sev-
eral HNSCC tumor cells produce soluble factor(s) that 
may be responsible for the migration of the MSC to the 
local microenvironment.
PDGFs and IL‑6 are major factors implicated 
in HNSCC‑mediated MSC chemotaxis
Next, the conditioned media from OKTs, JHU-011, JHU-
12 and -019 was analyzed for >50 chemokines and growth 
factors previously shown to be important in the patho-
physiology of human cancer (Additional file 5: Figure S6). 
Eight growth factors and chemokines were identified as 
potential chemotactic factors (Additional file  6: Figure 
S7), of which IL-6, PDGF-AA, PDGF-BB and PDGF-AB 
independently caused a significant migration of MSCs 
comparable to that observed with JHU-019 (Fig.  5a, 
*p < 0.0001). Neutralizing antibodies were used to inhibit 
IL-6 or PDGF in the condition media to determine which 
chemokine was the primary driver of MSC chemot-
axis in this setting. Neutralization of PDGF resulted in 
a  >50% reduction in 3/3 HNSCC cell lines with a near 
complete arrest of MSC chemotaxis in 2/3 HNSCC cell 
lines (Fig. 5b; *p < 0.0001) whereas neutralization of IL-6 
resulted in a ~50% reduction in MSC chemotaxis in 1/3 
cell lines (Fig.  5c; *p  <  0.0001, **p  <  0.03). The negative 
migration response reflects a decrease in the percent-
age of MSC chemotaxis compared to OKT control cells. 
A similar response was observed when the IL6 and 
PDGF receptors were blocked in the upper chamber of 
the transwells (data not shown). Expression of PDGFRα 
and PDGFRβ was found to be exclusively present on the 
membrane of MSCs and not HNSCC cells lines JHU-011, 
-012, -019 or -022 (Fig. 5d). However, the IL-6 receptor 
and the IL-6 transducer, gp130, were found on the sur-
face of both HNSCC cancer cells and MSCs (Additional 
Fig. 2 The MSC markers Gremlin-1 and CD90 are co-localized in the TM of patients with OCSCC (oral tongue). High power resolution confocal 
images from representative sections of 2 (T1 and T2) human OCSCC specimens (A–H) and adjacent normal (N) tissue (I–L) are shown. Grem-
lin-1+ cells (red; A, F) and CD90+ (blue; C, G) are identified in the TM and to a lesser extent adjacent normal tissue (J, K). When the photomicro-
graphs are merged, co-localization of gremlin-1+ and CD90+ cells yields a magenta color (D, H). Additional, Z-stack image analysis with orthogonal 
sectioning (D, white arrow) demonstrates gremlin-1+/CD90+ cells (magenta color) in both the x and y planes
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file 7: Figure S8). Blockade of PDGFRα resulted in a sig-
nificant reduction of MSC chemotaxis whereas blockade 
of PDGFRβ did not (Fig. 5e; p < 0.0001).
To better understand if PDGF secretion by HNSCC 
tumor cells was dependent upon IL-6 or vice versa a 
multiplex bead assay approach was used to determine 
the kinetic secretory prolife. In both JHU-011 and -019 
cell lines, PDGF-AA was found to be secreted early and 
at significantly high levels compared to either PGDF-AB, 
-BB, or IL-6 (Fig. 6a–c, p < 0.007). After 48-h, PDGF-AA 
secretion remained elevated without evidence of reach-
ing a plateau, suggesting, PDGF-AA is likely the key 
chemotactic agent underlying MSC chemotaxis in 
HNSCC and may cause tumor cell release of IL-6 as a 
later phenomenon. Indeed, stimulation of JHU-011 and 
-019 with PDGF-AA resulted in a significant increase in 
IL-6 production compared to unstimulated cells, suggest-
ing the PDGF-AA mediates release of IL-6 in this setting 
(Fig.  6d–f). PDGF-AA secretion by HNSCC appears to 
function in a paracrine fashion, as PDGF-AA exclusively 
Fig. 3 High resolution Z-stack confocal imaging OCSCC was performed to determine if α-SMA+ myofibroblasts (green; panel B) in the TM co-
localized with the MSC markers Gremlin-1 (red; panel C) and CD90 (blue; panel D). On merged images (panel D), co-localization of gremlin-1 with 
CD90 yields a magenta color as indicated by the cross-hairs and white arrow. These cells are positive for the MSC markers gremlin and CD90 but not 
α-SMA. The nuclei are stained grey (panel A).
Fig. 4 Conditioned media from 3 well characterized OPSCC cells lines (JHU-011, -012, and -019) caused significant migration and invasion of MSCs. 
Following 24-h incubation with conditioned media from JHU-011, -012, and -019, a >60% increase in MSC migration was observed when compared 
to OKT controls (a). MSCs were also observed to have a significant increased capacity for invasion >50% compared to that caused by the condi-
tioned media from OKT controls (b). All data are expressed as a percentage increase in MSC migration and invasion normalized to OKT controls. 
Each experiment was performed in triplicate for n ≥ 3 (p < 0.0001)
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signals through the PDGFα receptor, which was present 
in MSCs, but absent in JHU-011, -12, or -019 (Fig. 5d).
Discussion
The overall survival rate for advanced head and neck 
squamous carcinoma cell (HNSCC) is dismal (<25%), 
and these statistics have remained largely unchanged 
for decades despite advances in surgical technique and 
multimodality therapy. This low survival and absence of 
efficient therapies exist because of a gap in knowledge 
about pathophysiology of the HNSCC tumor microen-
vironment giving rise to an unmet need in the >500,000 
patients diagnosed annually with HNSCC. MSCs have 
been shown to home early to the tumor microenviron-
ment of several columnar, epithelial, and CNS cancers 
(breast [7, 17], ovarian [6], gastric [4], melanoma [12], 
glioma [18]) and evade host immune responses [19]. 
The vast majority OC and OPSCC arises in the set-
ting of long standing tobacco and/or alcohol abuse, 
resulting in a chronic state of inflammation [20]. MSCs 
have been shown to migrate in response to chemotac-
tic stimuli secreted during tissue injury, inflammation, 
and cancer [6, 21]. Therefore, the presence of MSCs in 
microenvironment of OC and OPSCC is likely. How-
ever, studies demonstrating the presence of MSCs in 
the HNSCC tumor microenvironment are just emerg-
ing. Liotta et al. recently reported MSCs to be enriched 
in CD90+ stromal fraction of cells isolated from HNSCC 
tumors [8]. We have expanded on this emerging concept 
and demonstrate the presence of gremlin-1 +/CD90 +/
CD105 + MSCs in tumor microenvironment of patients 
with OC and OPSCC (Figs. 1, 2, 3).
MSC mediated chemotaxis to the HNSCC tumor 
microenvironment is dependent upon tumor cell secre-
tion of PDGF-AA and this mechanism of tumor driven 
recruitment of stem/stromal cells to the microenvi-
ronment has not been previously reported in HNSCC. 
Tumor microenvironment expression of PDGFR-α 
has been shown to correlate with a worse prognosis in 
patients with prostate, breast, ovarian, non-small cell 
lung cancer and osteosarcoma.
The PDGF-AA isoform is an important regula-
tory molecule in cell migration, wound healing that is 
thought to be among the most potent stimuli for cells of 
Fig. 5 Seven chemokines and growth factors were noted to be highly secreted in the conditioned media of JHU-011 and JHU-019. Of those, only 
recombinant IL-6 and PDGF isoforms AA, BB, and AB independently caused significant migration of MSCs to levels comparable to OPSCC cell line 
JHU-019 when compared to 1% BSA treated media (a). Neutralizing antibodies to all PDGF isoforms (b) and IL-6 (c) in the conditioned media of cell 
lines JHU-011, -012, and -019 and/or -022 resulted in a significant reduction in MSC migration. PDGFRα and PDGFRβ was expressed on MSCs and 
not JHU-011, -012, -019 or JHU-022. 3T3 cells were used as a negative control (d). Only blockade of PDGFRα but not PDGFRβ resulted in a significant 
reduction in JHU-011 induced MSC chemotaxis. Two MSC passes P3 and P5 were used to ensure MSC passage did not affect PDGFR expression. 
Each experiment was performed in triplicate for n ≥ 3 and unless where indicated (*p < 0.0001, **p < 0.03)
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mesenchymal origin. This highly specific PDGF isoform 
signals only through the PDGF-α receptor which was not 
present on the surface of our OPSCC cells, suggesting a 
paracrine signaling mechanism is operate in OPSCC. We 
have shown here that PDGF-AA causes a ~100% increase 
in the migration of HMSCs compared to OKT cells and 
neutralization of PDGF in the conditioned media from 
OPSCC cell lines resulted in arrest of MSC chemot-
axis to levels comparable with controls (Fig.  5b). Neu-
tralization of IL-6 resulted in reduced HNSCC-induced 
HMSC chemotaxis (Fig.  5c), however the net reduction 
observed was less than that with PDGF inhibition alone. 
Our hypothesis that PDGF-AA is the primary driver of 
MSC chemotaxis in OPSCC is further strengthened as 
inhibition of only the PDGFRα significantly reduced 
MSC migration (Fig.  6e). Although both PDGFRα and 
PDGFRβ were found on the surface of MSCs, PDGF-AA 
only activates the PDGFRα not PDGFRβ, and inhibition 
of PDGFRβ did not cause the same magnitude of reduced 
chemotaxis as inhibition of PDGFRα.
PDGFR-mediated signaling pathways are highly asso-
ciated with cancer progression. PDGFRα and PDGFRβ 
expression on breast cancer and the surrounding tumor 
stroma has been shown to be highly correlated with tumor 
aggressiveness and metastasis, respectively [22]. Imatinib, 
a selective inhibitor of PDGFR, was found to impair the 
tumor promoting effects of bone marrow derived MSCs 
in an orthotopic model of colon cancer [23]. Chayama 
et al. found cultured KM12SM colon cancer cells secreted 
PDGFβ but lacked expression of PDGFRβ [24]. Treat-
ment with imatinib inhibited MSC migration, and sig-
nificantly inhibited the tumor-promoting effects of MSCs 
and reduced the formation of liver metastasis. Further-
more, paracrine activation of PDGFRs has previously 
been reported to be important for the development of the 
surrounding tumor stroma which is largely thought to be 
derived from differentiated MSCs [22].
We have observed a similar paracrine activation signal-
ing in OPSCC through tumor cell secretion of PDGF-AA. 
Our data suggest that PDGF-AA is a more potent MSC 
chemoattractant in OC and OPSCC, than other PDGF 
isoforms and IL-6. Previous reports have shown that the 
PDGF-AA, -AB, and -BB stimulates the transcription 
of the IL-6 gene in normal, nontransformed fibroblasts, 
vascular smooth muscle cells and mesangial cells [25]. 
Moreover, activation of the IL-6 gene was shown to serve 
Fig. 6 Secretion of PDGF-AA (a), PDGF-BB/AB (b), and IL-6 (c) were quantified over time using a magnetic bead assay approach. Concentrations of 
PDGF-AA rose earlier and were significantly higher than PDGF-BB, -AB or IL-6 in the conditioned media of JHU-011 and -019 (p < 0.007). To deter-
mine if PDGF-AA mediated secretion of IL-6, JHU-011 and -019 cells were treated with 5 ng PGGF-AA and IL-6 secretion compared to unstimulated 
cells (d, e). Stimulation with PDGF-AA resulted in a significant increase in IL-6 secretion (p < 0.001). All experiments performed in duplicate for n = 2 
observations
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as a key mechanism for proliferation of these cells of mes-
enchymal origin [31]. IL-6 working in an autocrine feed-
back loop on tumor cells and MSCs may further drive 
proliferation in this setting. The relationship and biologic 
significance between PDGF and IL-6 in the setting of OC 
and OPSCC is under active investigation in our lab.
Conclusions
Our data suggests that HNSCC tumor cells production of 
PDGF-AA and IL-6 may be responsible to the increased 
tropism of MSC to the tumor site, which lays the foun-
dation for further study in the MSCs in this context and 
the development of novel cellular/chemokines targeting 
therapies for this cancer.
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seen representing cells of hematopoietic lineage (A-C). The black box 
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OCSCC specimens (A) demonstrate TM cells positive for the MSC markers 
anti-gremlin-1 (red) and anti-CD105 (green). An orange color on merged 
images indicates co-localization of gremlin-1 and CD105. In addition, 
TM MSCs were detected by anti-gremlin-1 (red) and anti-CD90 (blue). A 
magenta color on merged images indicates co-localization of gremlin and 
CD90 that did not co-localize with the hematopoietic marker, anti-CD45 
(green) (B). The nuclei are depicted as grey.
Additional file 4: Figure S5. Conditioned media from 3 well character-
ized OPSCC cells lines (JHU-011, -012, and -019) caused significant migra-
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24-hour incubation with conditioned media from JHU-011, -012, and -019, 
a > sevenfold increase in MSC migration was observed when compared 
to serum free controls (A). MSCs were also observed to have a significant 
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IL-8, IL-6, and PDGF were found to be highly secreted compared to the 
conditioned media from OKT controls. Experiments were performed in 
duplicate for n = 3 observations.
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assays were conducted on SDF-1α, VEGF, Gro-α, IL-8, IL-6, and PDGF with 
the addition of CXCL7 to confirm the observations made in Additional 
file 1: Figure S6.
Additional file 7: Figure S8. The IL-6 receptor and gp130 was expressed 
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were performed in triplicate.
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